Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor - PubMed (original) (raw)

Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor

H Wakasugi et al. Proc Natl Acad Sci U S A. 1987 Feb.

Abstract

We report the establishment of a spontaneous interleukin 1 (IL-1)-producing subclone derived from the human Epstein-Barr virus (EBV)-containing B-lymphoblastoid cell line (721 LCL) and show that the IL-1 produced by this B-cell subclone is distinct from other types of IL-1. The parental cell line 84.5, a deletion mutant of the 721 LCL cell line, can be induced to produce IL-1 activity when stimulated by certain inducers such as phorbol 12-myristate 13-acetate in the presence of fetal calf serum. From this parental 721/84.5 clone, a subclone, termed 3B6, has been developed. This 3B6 subclone has an immature B-cell phenotype, expresses only HLA class II DP subregion antigens, and spontaneously releases IL-1 in the culture supernatant with relatively few inhibitory molecules under serum-free culture conditions. The 3B6-derived IL-1 was purified from 3B6 conditioned medium with a three-step procedure. The molecular weight of this IL-1 is 13,500, and the isoelectric point values are pH 4.9 and 5.1 without any component focusing near pH 7. The N-terminal amino acid sequence differs markedly from those reported for the two IL-1 species produced by monocytes. The purified material shares several biological properties with monocyte IL-1, since it could induce the proliferation of murine thymocytes, the production of interleukin 2 by phytohemagglutinin-stimulated cloned HSB2 T cells, and the proliferation of human fibroblasts. However, this IL-1 activity could not be blocked by polyclonal anti-monocytic IL-1 antibodies, and, more importantly, it was not pyrogenic in rabbits. Finally, it promotes the growth of B-cell clones derived from the parental 721/84.5 lines in the absence of fetal calf serum, which suggests that it could act as an autocrine growth factor in this Epstein-Barr virus-transformed B-cell line.

PubMed Disclaimer

Cited by

Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1.
Schenk H, Klein M, Erdbrügger W, Dröge W, Schulze-Osthoff K. Schenk H, et al. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1672-6. doi: 10.1073/pnas.91.5.1672. Proc Natl Acad Sci U S A. 1994. PMID: 8127864 Free PMC article.
Human plasma accelerates immortalization of B lymphocytes by Epstein-Barr virus.
Manor E. Manor E. Cell Prolif. 2008 Apr;41(2):292-8. doi: 10.1111/j.1365-2184.2008.00513.x. Cell Prolif. 2008. PMID: 18336473 Free PMC article.
Growth of B95-8 cells and expression of Epstein-Barr virus lytic phase in serum-free medium.
Shaw JE, Petit RG, Leung K. Shaw JE, et al. J Virol. 1987 Dec;61(12):4033-7. doi: 10.1128/JVI.61.12.4033-4037.1987. J Virol. 1987. PMID: 2824833 Free PMC article.
Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.
Shaw JE, Baglia LA, Leung K. Shaw JE, et al. J Virol. 1988 Sep;62(9):3415-21. doi: 10.1128/JVI.62.9.3415-3421.1988. J Virol. 1988. PMID: 2841494 Free PMC article.
A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene.
Taniguchi Y, Taniguchi-Ueda Y, Mori K, Yodoi J. Taniguchi Y, et al. Nucleic Acids Res. 1996 Jul 15;24(14):2746-52. doi: 10.1093/nar/24.14.2746. Nucleic Acids Res. 1996. PMID: 8759006 Free PMC article.

References

1. J Exp Med. 1980 Jun 1;151(6):1551-6 - PubMed
1. J Immunol. 1978 Jun;120(6):2027-32 - PubMed
1. J Immunol. 1982 May;128(5):2177-82 - PubMed
1. Proc Natl Acad Sci U S A. 1983 Oct;80(19):6028-31 - PubMed
1. J Immunol. 1984 Apr;132(4):1837-44 - PubMed

Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor - PubMed (original) (raw)